Glucotrack, Inc. (GCTK) stock
GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.68−0.04 (-5.56%)
Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –
Glucotrack EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Glucotrack's EPS for the twelve months ending Sep 30, 2020 was -$21.01. For fiscal 2025 it was $31.22, down 99.2% from the year before. The highest annual figure on record is $4106.00 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $31.22 | -99.2% |
| FY2024 | Dec 31, 2024 | $4106.00 | +100.2% |
| FY2023 | Dec 31, 2023 | $2050.80 | +2257.2% |
| FY2022 | Dec 31, 2022 | $87.00 | +11.5% |
| FY2021 | Dec 31, 2021 | $78.00 | +36.8% |
| FY2020 | Dec 31, 2020 | $57.00 | – |
| FY2019 | Dec 31, 2019 | -$0.08 | – |
| FY2018 | Dec 31, 2018 | -$18.47 | – |
| FY2017 | Dec 31, 2017 | -$7.29 | – |
| FY2016 | Dec 31, 2016 | -$4.21 | – |
| FY2015 | Dec 31, 2015 | -$4.48 | -410.8% |
| FY2014 | Dec 31, 2014 | $1.44 | – |
| FY2013 | Dec 31, 2013 | -$7.60 | – |
| FY2012 | Dec 31, 2012 | -$2.03 | – |
| FY2011 | Dec 31, 2011 | -$1.79 | – |
| FY2010 | Dec 31, 2010 | -$2.73 | -333.3% |
| FY2009 | Dec 31, 2009 | $1.17 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.76 | -98.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.65 | -99.8% |
| Q3 FY2025 | Sep 30, 2025 | $4.64 | -99.5% |
| Q2 FY2025 | Jun 30, 2025 | $9.62 | – |
| Q1 FY2025 | Mar 31, 2025 | $40.14 | – |
| Q3 FY2024 | Sep 30, 2024 | $1092.00 | +6640.7% |
| Q2 FY2024 | Jun 30, 2024 | $984.00 | – |
| Q1 FY2024 | Mar 31, 2024 | -$703.80 | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.40 | – |
| Q2 FY2023 | Jun 30, 2023 | $16.20 | – |
| Q1 FY2023 | Mar 31, 2023 | -$24.00 | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.00 | – |
| Q2 FY2022 | Jun 30, 2022 | -$21.00 | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.00 | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.00 | – |
| Q1 FY2021 | Mar 31, 2021 | $0.00 | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.00 | – |
| Q2 FY2020 | Jun 30, 2020 | -$12.00 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.00 | – |
| Q4 FY2019 | Dec 31, 2019 | -$0.01 | – |
| Q3 FY2019 | Sep 30, 2019 | -$0.04 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.04 | -102.9% |
| Q1 FY2019 | Mar 31, 2019 | -$0.04 | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.21 | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.29 | -168.7% |
| Q1 FY2018 | Mar 31, 2018 | $1.32 | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.71 | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.87 | – |
| Q1 FY2017 | Mar 31, 2017 | $1.87 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.93 | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.17 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?